You should be expecting CR when investing in biotech start-up stock. What do you think the pps will be after completion of Ph1 for CR? And then end of Ph2 for CR? And then end of Ph3 for CR? And then regulator approval for CR? And then commercialisation for CR?
You should be expecting CR when investing in biotech start-up...
-
- There are more pages in this discussion • 951 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17059 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 100000 | 1 |
View Market Depth
| Last trade - 09.18am 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable